Abstract
Introduction
The Inula genus comprises more than one hundred species, mainly distributed in Africa, Asia and Europe, predominantly, in the Mediterranean Area. Compounds isolated from the species of this genus are mono-, sesqui-, di-and triterpenes, flavonoids and inositol derivatives. Cyclic sesquiterpenes are the predominant constituents of Inula genus [1] [2] [3] . Alcoholic and oil preparations of the flowering aerial parts of this plant are widely used in the traditional medicine of Provence (France) in the treatment of hematomas, as well as Arnica montana L. [4] . However, its phytochemical composition has been poorly investigated [5] [6] [7] [8] . Only six sesquiterpene lactones, four free flavonoid aglycones and volatile composition have been reported in Inula montana L. until now [5, 6] .
Antioxidant and anti-protozoocidal activities of Inula montana extracts have been previously reported as well. No anti-inflammatory activity has been investigated comparing to Inula cappa or Inula wissmanniana [3, [7] [8] [9] . In this study, we describe the isolation of sixteen compounds for the first time from Inula montana L., including five new ones. The anti-inflammatory activity of the isolated compounds has been also evaluated.
Experimental part

General
Optical rotations were measured using Anton Paar polarimeter (l=10 mm, ∅=5 mm, Ref. 279986.05) . UV spectra were recorded on Shimadzu UV-1650pc spectrophotometer. IR spectra were recorded on Bruker Vertex 70 FT-IR with ATR module. 1D and 2D NMR spectra were recorded on Bruker AVANCE III 600 spectrometer ( 1 H 600.13MHz) with tetramethylsilane (TMS) as internal standard at 300K. Chemical shifts (δ) were expressed in ppm with TMS as an internal reference.
HR-ESI-MS was performed on SYNAPT G2 HDMS (Waters) spectrometer. UHPLC was performed on Agilent 1290 liquid chromatograph equipped with a Zorbax Eclipse Plus, C18 (100 × 2.1 mm, 2.8 µm) (Agilent) column. HPLC was performed on Agilent 1200 liquid chromatograph equipped with a Luna C18 (150 × 4.6 mm, 3 µm) column. Preparative HPLC was performed on Gilson PLC2020 with a Luna C18 (150 × 21.2 mm, 3 µm) column (Phenomenex). Flash chromatography was performed using a Teledyn Isco CombiFlash Rf 200 (USA). TLC analysis was performed on Silica F 254 plates (Merck).
The positive control dexamethasone, phosphate tampon, dimethyl sulfoxide, RAW 264.7 cells and Lyposaccharides (LPS) of E.coli were purchased from SigmaAldrich. Griess reagent was purchased from Promega.
Plant material
The plant I. montana was collected in Merindol (Luberon Natural Regional 
Extraction and isolation
The air-dried plant materials: leaves (0.2 kg) and flowers (0.2 kg), were extracted separately with EtOH 95% (v/v) (1.2 L × 3), by percolation at room temperature for 18 h, to afford crude extracts E2 (leaves, 8.6 g) and L2 (flowers, 23.7 g). After concentration in vacuo, each extract was suspended in H 2 O and partitioned by petroleum ether and dichloromethane successively, to provide a petroleum ether E2P (2.1 g) and dichloromethane E2D (1.0 g) extracts for leaves and petroleum ether L2P (4.4 g) and dichloromethane L2D (0.7 g) extracts for flowers.
The leaves dichloromethane extract E2D (0.9 g) was subjected to reversed phase silica gel (C18, 100 g) flash chromatography and eluted with water/methanol MeOH-H 2 O (0-30 min 35-85% MeOH, 30-31 min 85-100% MeOH, 31-35 min 100% MeOH (v/v), flow rate: 40 mL/min) to afford three fractions (E2D1), (E2D2), (E2D3) and three compounds 6 (0.3 mg), 7 (19.2 mg) and 8 (0.3 mg). Fraction E2D1 (50.5 mg) was subjected to preparative HPLC (C18, 3 µm,150 × 21.2 mm, flow rate 10.6 mL/min, wavelength 225 nm) using MeOH-H 2 O system (52-48, v/v) which gave two compounds: 2 (12 mg) and 3 (12.7 mg). Fraction E2D2 (50.7 mg) was separated by preparative HPLC (C18, 3 µm,150 × 21.2 mm, flow rate 10.6 mL/min, wavelength 210 nm) using MeOH-H 2 O system (42-58, v/v) which afforded compounds 9 (0.3 mg), 10 (0.2 mg) and 11 (0.5 mg). Fraction E2D3 (12.7 mg) has been found to be as the mix of two compounds 4 and 5.
The flowers petroleum ether extract L2P (2.1 g) was subjected to silica gel Fraction L2D (0.6 g) was subjected to reversed phase silica gel (C18, 100 g) flash chromatography and eluted with the same conditions as the fraction E2D to afford one fraction (L2D1) and two compounds 14 (15 mg) and 15 (5 mg 
Anti-inflammatory and cytotoxicity assays
In vitro anti-inflammatory assay is based on the ability of immortalized mouse macrophages RAW 264.7 to generate a strong inflammatory response leading to NO The concentrations of the test material causing respectively a 50% decrease of NO release (IC 50-NO release ) and a 50% decrease of cell viability (IC 50-cell viability ) were calculated through non-linear regression analysis using software Tablecurve Version 2.0. The anti-inflammatory ratio was defined as the ratio between anti-inflammatory activity and toxicity. It was expressed as follows:
Anti-inflammatory ratio = IC 50 cell viability / IC 50 NO release
Results and Discussion
One new sesquiterpene acid, called Eldarin (1) and identified in our study [6] . Compound 1 (Fig. 1) (Fig. 3) . Compound 1 was previously proposed by Zdero et al.,
as a possible intermediate compound in the transformation of germacrene A acid to the desacetyl derivative of compound 1, but it has never been isolated [19] . In our study, the structure of compound 1 isolated from I. montana is elucidated as shown, and this compound is called Eldarin. ppm corresponding of an isovaleroyl moiety. The HMBC spectrum (Fig. 3) showed that H-6 at 5.65 ppm (t, 10.0) is connected with the isovaleroyl carbonyl at 172.9
ppm, thus, compound 5 was established as myoinositol-1-angelate-4,5-diacetate-6-isovalerate. Table 4 Anti-inflammatory, cytotoxic activity and anti-inflammatory ratio of compounds 1-3, 7, 12-16 
